NCT01055535View on ClinicalTrials.gov

Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Focal Vitreomacular Adhesion
Interventions
DRUG

Microplasmin

125 µg intravitreal injection

Trial Locations (1)

Unknown

University Hospital Leuven, Leuven

Sponsors

Lead Sponsor

ThromboGenics
All Listed Sponsors
lead

ThromboGenics

INDUSTRY